Cancer Care at the Crossroads 2018 Program

The Third One-Day International Summit on Innovation, Clinical Benefit and Cost
New York Genome Center

DATE & TIME

Friday,

March 23, 2018

8:00am - 4:30pm

LOCATION

New York Genome Center,

101 Avenue of the Americas,

New York, NY

OPENING REMARKS
8:00am - 8:15am

Mike Meyer

President, Meyer Consulting

William Henrich

MD, President and Professor of Medicine, UT Health San Antonio

ROUND TABLE 1
Cancer Care through the Lens of Health Plans, Academic Centers, Pharma and Provider Groups - What Has Happened in the last 12 months
8:15am - 9:30am

Moderator

Stephen Emerson

MD, PhD, Former Director, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center

Panelist

Clifford Hudis

MD, Chief Executive Officer, American Society of Clinical Oncology (ASCO)

Panelist

Jeffrey Le Benger

MD, Chairman and CEO, Summit Medical Group & Summit Health Management

Panelist

Mace Rothenberg

MD, Chief Development Officer, Oncology Global Product Development, Pfizer, Inc

Panelist

Maureen Sullivan

Chief Strategy and Innovation Officer, Blue Cross Blue Shield Association

ROUND TABLE 2
The Future of Cancer Treatment (Genomics, Precision Medicine, Immunotherapy, Car-T) and Genomics Driven Decision Making
9:30am - 10:45am

Opening Remarks
Moderator

Alexander Eggermont

MD, PhD, Director Gustave Roussy; Chairman, Cancer Core Europe

Panelist

Jeffrey Weber

MD, PhD, Deputy Director, Perlmutter Cancer Center, NYU, Langone Medical Center

Panelist

James Gulley

MD, PhD, Chief, GU Malignancies Branch and Head, Immunotherapy Group, GMB; Dir., Medical Oncology Services, Center for Cancer Research, NCI, NIH

Panelist

Michel Sadelain

MD, PhD, Director, Center for Cell Engineering, Memorial Sloan Kettering Cancer Center

Panelist

Eric H. Rubin

MD, SVP and Therapeutic Area Head, Oncology Early Development Merck

BREAK
10:45am - 11:00am
ROUND TABLE 3
New Innovations and Technology to Improve Prevention, Diagnosis, Integrated Care, Survivorship and Palliative Care
11:00am - 12:15pm

Opening Remarks
Moderator

Mary Ann Christopher

Vice President, Clinical Operations & Transformation, Horizon Blue Cross Blue Shield of New Jersey

Panelist

Michael J. Fisch

MD, MPH, Medical Director, Medical Oncology Programs and Genetics AIM Specialty Health

Panelist

Gary Schwartz

MD, Deputy Director, Herbert Irving Comprehensive Cancer Center

Panelist

Diane Meier

MD, Director, Center to Advance Palliative Care, Mount Sinai Health System, NYC

Panelist

Alan Bryce

MD, Vice Chair, Hematology & Medical Oncology and Medical Director, Genomic Oncology Clinic, Mayo Clinic Arizona

LUNCH SERVED AT CONFERENCE CENTER
12:15pm - 1:15pm
AFTERNOON REMARKS
1:15pm - 1:30pm

Peter Fine

President and CEO, Banner Health

ROUND TABLE 4
The Challenges Facing Health Plans, Providers and Governments in Financing Innovative Cancer Treatments in a Changing Health Care Policy Environment
1:30pm - 2:45pm

Moderator

Peter Fine

President and CEO, Banner Health

Panelist

Matthew Shaulis

President, North America Oncology, Pfizer

Panelist

Glen Stettin

MD, Chief Innovation Officer & Senior Vice President - Clinical, Research & New Solutions, Express Scripts

Panelist

Richard Sullivan

MD, PhD, Director, institute for Cancer Policy, King's College London

Panelist

Grace Stuntz

Health Policy Director, Senate HELP Committee Majority Staff, US Senate

BREAK
2:45pm - 3:00pm
ROUND TABLE 5
The Realities and Ethics of Innovative New Cancer Modalities/Types of Treatment (prevention, vaccines, immunotherapy, Car-T) and the Impact on Patients, Families, Industry and Media Perceptions
3:00pm - 4:15pm

Moderator

Robert Bazell

Professor Yale University, former Chief Health and Science Correspondent for NBC

Panelist

Fran Visco

President, National Breast Cancer Coalition

Panelist

Arthur Caplan

PhD, Mitty Chair and Director, Division of Medical Ethics NYU School of Medicine

Panelist

Sarah Iselin

SVP and Chief Strategy Officer, GuideWell / Florida Blue

Panelist

Oliver Elemento

PhD, Director, Englander Institute for Precision Medicine, Weill Cornell Medicine

CLOSING REMARKS
The Explosion of the Almost Science Fiction next Generation Treatments
4:15pm - 4:30pm

Jacque Sokolov

MD, Chairman and CEO, SSB Solutions

Mike Meyer

President, Meyer Consulting